Indoleamine 2,3 dioxygenase (IDO) is a potent immunomodulatory enzyme that has recently attracted significant attention for its potential application as an inducer of immunotolerance in transplantation. We have previously demonstrated that a collagen matrix populated with IDO-expressing fibroblasts can be applied successfully in suppressing islet allogeneic immune response. Meanwhile, a critical aspect of such immunological intervention relies largely on effective long-term expression of the IDO gene. Moreover, gene manipulation of primary cells is known to be challenging due to unsatisfactory expression of the exogenous gene. In this study, a lentiviral gene delivery system has been employed to transduce primary fibroblasts. We used polybr...
Indoleamine 2,3-dioxygenase (IDO) is an enzyme that is physiologically expressed in many tissues inc...
Cells that express indoleamine 2,3-dioxygenase (IDO), the rate-limiting enzyme in the catabolism of ...
Successful long-term treatment of type-1 diabetes mainly relies on replacement of β-cells via islet ...
Success of transplantation of pancreatic islets as a promising therapeutic method for restoring effi...
Indoleamine 2,3-dioxygenase (IDO) is an immunosuppressive enzyme with tolerogenic effects on differe...
Type 1 diabetes (T1D) is a devastating disease affecting more than 22 million people worldwide. Earl...
BACKGROUND: Since the discovery that indoleamine 2,3-dioxygenase (IDO) is a modulator for maintenanc...
Indoleamine 2,3-dioxygenase (IDO), an enzyme that plays a critical role in fetomaternal tolerance, e...
The expression of indoleamine 2,3-dioxygenase (IDO), which metabolizes tryptophan, an essential amin...
Background: Since the discovery that indoleamine 2,3-dioxygenase (IDO) is a modulator for maintenanc...
Background: Since the discovery that indoleamine 2,3-dioxygenase (IDO) is a modulator for maintenanc...
As a possible way of making a non-rejectable skin substitute, here, we ask the question of whether t...
Indolemine 2, 3-dioxygenase (IDO) is a cytosolic monomeric hemoprotein enzyme that catalyses tryptop...
Lipoaspirate, a wasted by product from liposuction procedure recently has been shown to contain abun...
Acute and chronic wounds contribute to increased morbidity and mortality in affected people and impo...
Indoleamine 2,3-dioxygenase (IDO) is an enzyme that is physiologically expressed in many tissues inc...
Cells that express indoleamine 2,3-dioxygenase (IDO), the rate-limiting enzyme in the catabolism of ...
Successful long-term treatment of type-1 diabetes mainly relies on replacement of β-cells via islet ...
Success of transplantation of pancreatic islets as a promising therapeutic method for restoring effi...
Indoleamine 2,3-dioxygenase (IDO) is an immunosuppressive enzyme with tolerogenic effects on differe...
Type 1 diabetes (T1D) is a devastating disease affecting more than 22 million people worldwide. Earl...
BACKGROUND: Since the discovery that indoleamine 2,3-dioxygenase (IDO) is a modulator for maintenanc...
Indoleamine 2,3-dioxygenase (IDO), an enzyme that plays a critical role in fetomaternal tolerance, e...
The expression of indoleamine 2,3-dioxygenase (IDO), which metabolizes tryptophan, an essential amin...
Background: Since the discovery that indoleamine 2,3-dioxygenase (IDO) is a modulator for maintenanc...
Background: Since the discovery that indoleamine 2,3-dioxygenase (IDO) is a modulator for maintenanc...
As a possible way of making a non-rejectable skin substitute, here, we ask the question of whether t...
Indolemine 2, 3-dioxygenase (IDO) is a cytosolic monomeric hemoprotein enzyme that catalyses tryptop...
Lipoaspirate, a wasted by product from liposuction procedure recently has been shown to contain abun...
Acute and chronic wounds contribute to increased morbidity and mortality in affected people and impo...
Indoleamine 2,3-dioxygenase (IDO) is an enzyme that is physiologically expressed in many tissues inc...
Cells that express indoleamine 2,3-dioxygenase (IDO), the rate-limiting enzyme in the catabolism of ...
Successful long-term treatment of type-1 diabetes mainly relies on replacement of β-cells via islet ...